Just using your logic. "They are trialling on v sick patients wow it must therefore be great as first in line - it will get instantly approved as SOc". unfortunately doesn't work that way.
yep thats where IMU azercell sits - third in line. This is good - a reasonable pool of patients. The highlighted part is just saying the pool of patients might get bigger as carT moves up (not that Azer cell will.move up 2nd)
Again - you were saying "very low risk it wont becomes SOC." Do you concede that this is not true, that azer cell is not trialiing for SOC?.
You could give it another seven years and it would be amazing if Azer cell became SOC in that time let alone that happening at all.
IMU Price at posting:
4.1¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)